People with Parkinson's design Clinical Trials Charter to improve communication about, recruitment to, and retention in Parkinson's clinical trials

被引：0
|
作者：
Mathur, S. [1 ,2 ]
DeWitte, S. [2 ,3 ]
Robledo, I. [2 ,3 ]
Isaacs, T. [2 ,4 ]
Stamford, J. [2 ,4 ]
机构：
[1] Designing Cure Inc, Toronto, CA USA
[2] Parkinsons Movement, London, England
[3] Parkinsons Act Network, Washington, DC USA
[4] Cure Parkinsons Trust, London, England
来源：
MOVEMENT DISORDERS | 2015年 / 30卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
8
引用
收藏
页码：E4 / E5
页数：2
相关论文
共 50 条
  • [21] New Clinical Trials for Nonmotor Manifestations of Parkinson's Disease
    Schrag, Anette
    Sauerbier, Anna
    Chaudhuri, Kallol Ray
    MOVEMENT DISORDERS, 2015, 30 (11) : 1490 - 1503
  • [22] Patterns of outcome measurement in Parkinson's disease clinical trials
    Mitchell, SL
    Harper, DW
    Lau, A
    Bhalla, R
    NEUROEPIDEMIOLOGY, 2000, 19 (02) : 100 - 108
  • [23] Parkinson's disease: From human genetics to clinical trials
    van der Brug, Marcel P.
    Singleton, Andrew
    Gasser, Thomas
    Lewis, Patrick A.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (305)
  • [24] Impact of placebo assignment in clinical trials of Parkinson's disease
    Goetz, CG
    Janko, K
    Blasucci, L
    Jaglin, JA
    MOVEMENT DISORDERS, 2003, 18 (10) : 1146 - 1149
  • [25] Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease
    Arnulf, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S204 - S204
  • [26] Representational Disparities in the Enrollment of Parkinson's Disease Clinical Trials
    Tsai, Chia-Chen
    Tao, Brendan
    Lin, Vallen
    Lo, Jaden
    Brahmbhatt, Suhangi
    Kalo, Carmen
    Marras, Connie
    Khosa, Faisal
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
  • [27] Status and future directions of clinical trials in Parkinson's disease
    Soderbom, Grazyna
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 153 - 188
  • [28] How can we improve the design and endpoints of symptomatic and disease modifying clinical trials in Parkinson's disease?
    Clarke, C. E.
    BASAL GANGLIA, 2012, 2 (04) : 201 - 204
  • [29] AGE BIAS IN CLINICAL TRIALS OF PARKINSON'S DISEASE TREATMENT
    Rajapakse, Anoja
    Rajapakse, Senaka
    Playfer, Jeremy
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (12) : 2353 - 2354
  • [30] An overview of the active clinical trials for Parkinson's disease psychosis
    Kwan, Cynthia
    Huot, Philippe
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2022, 12 (04) : 165 - 170
12345